Cargando…
pHLIP ICG for delineation of tumors and blood flow during fluorescence-guided surgery
Fluorescence imaging has seen enduring use in blood flow visualization and is now finding a new range of applications in image-guided surgery. In this paper, we report a translational study of a new fluorescent agent for use in surgery, pHLIP ICG, where ICG (indocyanine green) is a surgical fluoresc...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7591906/ https://www.ncbi.nlm.nih.gov/pubmed/33110131 http://dx.doi.org/10.1038/s41598-020-75443-5 |
_version_ | 1783601084813541376 |
---|---|
author | Crawford, Troy Moshnikova, Anna Roles, Sean Weerakkody, Dhammika DuPont, Michael Carter, Lukas M. Shen, John Engelman, Donald M. Lewis, Jason S. Andreev, Oleg A. Reshetnyak, Yana K. |
author_facet | Crawford, Troy Moshnikova, Anna Roles, Sean Weerakkody, Dhammika DuPont, Michael Carter, Lukas M. Shen, John Engelman, Donald M. Lewis, Jason S. Andreev, Oleg A. Reshetnyak, Yana K. |
author_sort | Crawford, Troy |
collection | PubMed |
description | Fluorescence imaging has seen enduring use in blood flow visualization and is now finding a new range of applications in image-guided surgery. In this paper, we report a translational study of a new fluorescent agent for use in surgery, pHLIP ICG, where ICG (indocyanine green) is a surgical fluorescent dye used widely for imaging blood flow. We studied pHLIP ICG interaction with the cell membrane lipid bilayer, the pharmacology and toxicology in vitro and in vivo (mice and dogs), and the biodistribution and clearance of pHLIP ICG in mice. The pHLIP ICG tumor targeting and imaging efficacy studies were carried out in several murine and human mouse tumor models. Blood vessels were imaged in mice and pigs. Clinical Stryker imaging instruments for endoscopy and open surgery were used in the study. Intravenously administered pHLIP ICG exhibits a multi-hour circulation half-life, offering protracted delineation of vasculature. As it clears from the blood, pHLIP ICG targets tumors and tumor stroma, marking them for surgical removal. pHLIP ICG is non-toxic, marks blood flow for hours after injection, and effectively delineates tumors for improved resection on the day after administration. |
format | Online Article Text |
id | pubmed-7591906 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-75919062020-10-28 pHLIP ICG for delineation of tumors and blood flow during fluorescence-guided surgery Crawford, Troy Moshnikova, Anna Roles, Sean Weerakkody, Dhammika DuPont, Michael Carter, Lukas M. Shen, John Engelman, Donald M. Lewis, Jason S. Andreev, Oleg A. Reshetnyak, Yana K. Sci Rep Article Fluorescence imaging has seen enduring use in blood flow visualization and is now finding a new range of applications in image-guided surgery. In this paper, we report a translational study of a new fluorescent agent for use in surgery, pHLIP ICG, where ICG (indocyanine green) is a surgical fluorescent dye used widely for imaging blood flow. We studied pHLIP ICG interaction with the cell membrane lipid bilayer, the pharmacology and toxicology in vitro and in vivo (mice and dogs), and the biodistribution and clearance of pHLIP ICG in mice. The pHLIP ICG tumor targeting and imaging efficacy studies were carried out in several murine and human mouse tumor models. Blood vessels were imaged in mice and pigs. Clinical Stryker imaging instruments for endoscopy and open surgery were used in the study. Intravenously administered pHLIP ICG exhibits a multi-hour circulation half-life, offering protracted delineation of vasculature. As it clears from the blood, pHLIP ICG targets tumors and tumor stroma, marking them for surgical removal. pHLIP ICG is non-toxic, marks blood flow for hours after injection, and effectively delineates tumors for improved resection on the day after administration. Nature Publishing Group UK 2020-10-27 /pmc/articles/PMC7591906/ /pubmed/33110131 http://dx.doi.org/10.1038/s41598-020-75443-5 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Crawford, Troy Moshnikova, Anna Roles, Sean Weerakkody, Dhammika DuPont, Michael Carter, Lukas M. Shen, John Engelman, Donald M. Lewis, Jason S. Andreev, Oleg A. Reshetnyak, Yana K. pHLIP ICG for delineation of tumors and blood flow during fluorescence-guided surgery |
title | pHLIP ICG for delineation of tumors and blood flow during fluorescence-guided surgery |
title_full | pHLIP ICG for delineation of tumors and blood flow during fluorescence-guided surgery |
title_fullStr | pHLIP ICG for delineation of tumors and blood flow during fluorescence-guided surgery |
title_full_unstemmed | pHLIP ICG for delineation of tumors and blood flow during fluorescence-guided surgery |
title_short | pHLIP ICG for delineation of tumors and blood flow during fluorescence-guided surgery |
title_sort | phlip icg for delineation of tumors and blood flow during fluorescence-guided surgery |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7591906/ https://www.ncbi.nlm.nih.gov/pubmed/33110131 http://dx.doi.org/10.1038/s41598-020-75443-5 |
work_keys_str_mv | AT crawfordtroy phlipicgfordelineationoftumorsandbloodflowduringfluorescenceguidedsurgery AT moshnikovaanna phlipicgfordelineationoftumorsandbloodflowduringfluorescenceguidedsurgery AT rolessean phlipicgfordelineationoftumorsandbloodflowduringfluorescenceguidedsurgery AT weerakkodydhammika phlipicgfordelineationoftumorsandbloodflowduringfluorescenceguidedsurgery AT dupontmichael phlipicgfordelineationoftumorsandbloodflowduringfluorescenceguidedsurgery AT carterlukasm phlipicgfordelineationoftumorsandbloodflowduringfluorescenceguidedsurgery AT shenjohn phlipicgfordelineationoftumorsandbloodflowduringfluorescenceguidedsurgery AT engelmandonaldm phlipicgfordelineationoftumorsandbloodflowduringfluorescenceguidedsurgery AT lewisjasons phlipicgfordelineationoftumorsandbloodflowduringfluorescenceguidedsurgery AT andreevolega phlipicgfordelineationoftumorsandbloodflowduringfluorescenceguidedsurgery AT reshetnyakyanak phlipicgfordelineationoftumorsandbloodflowduringfluorescenceguidedsurgery |